Moderna (MRNA:NSD) RBC Maintained “Outperform” rating
Analyst Ratings Coverage RBC Capital Markets (Rank#3), reiterated its outlook on Moderna by maintaining an “Outperform” rating. This reaffirmation of confidence was…
Browse research
Tag: MRNA:NSD
Moderna (MRNA:NSD) STA Research Maintains “Underperform” Rating
Analyst Ratings Coverage STA Research (Analyst Rank #29 of #350) issued a research report on Moderna Inc., on Monday September 18th, and maintained…